Status:

ENROLLING_BY_INVITATION

Ti-Mesh Frame Comparison for Alveolar Bone Augmentation

Lead Sponsor:

Boston University

Conditions:

Tooth Loss

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This research compares a chairside Titanium Mesh frame fabrication used during bone grafting procedures with the use of a computer-aided design/computer-assisted manufacture (CAD-CAM) Titanium Mesh fr...

Eligibility Criteria

Inclusion

  • Partially edentulous
  • Adult dental patients that require moderate 3-D bone augmentation for dental implant site improvement

Exclusion

  • Poor oral hygiene indices for microbial plaque (PI) and gingival inflammation (GI)
  • Patients who have been on Chemotherapy or Radiation therapy within last 5 years.
  • Patients under active treatment with following medications: Bisphosphonates, Gabapentin, Glucocorticoids, Methotrexate, or Estrogen supplements.
  • Subjects under the direct supervision of the PI
  • Smoking more than 10 cigarettes per day
  • Uncontrolled diabetes or other metabolic disorders

Key Trial Info

Start Date :

January 25 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06077513

Start Date

January 25 2024

End Date

September 1 2026

Last Update

March 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BU Goldman School of Dental Medicine

Boston, Massachusetts, United States, 02118

Ti-Mesh Frame Comparison for Alveolar Bone Augmentation | DecenTrialz